Fox News
Alzheimer’s blood marker could predict cognitive decline risks, says Mayo Clinic
Wednesday, November 18, 2026
Researchers at Mayo Clinic identified a blood test measuring p-tau217 that may predict cognitive decline risk within five to 10 years, according to a study released by the institution. The test offers an alternative to positron emission tomography scans, which require more invasive procedures. Mayo Clinic did not specify the sample size, participant demographics, or timeline for clinical availability.
Original reporting:
